Uncategorized

Win the Patent War Before the Drug Goes Generic: How Paragraph IV Challenges and Pay-for-Delay Settlements Decide Who Gets Paid — and Who Gets Blocked

In the high-stakes world of pharmaceuticals, the battle over patent rights isn’t just a legal skirmish—it’s a multi-billion-dollar war that shapes access to life-saving medications, influences healthcare costs, and determines the fate of innovation. Ye…

Win the Patent War Before the Drug Goes Generic: How Paragraph IV Challenges and Pay-for-Delay Settlements Decide Who Gets Paid — and Who Gets Blocked Read Post »

Uncategorized

Find the Money Before the Patent Dies: How to Identify Out-Licensing Targets Near Drug Patent Expiry — and Capture Value That Most Companies Leave on the Table

Unlocking Hidden Value in Pharma: How to Identify Out-Licensing Opportunities Before Patent Expiry
In the fiercely competitive world of pharmaceuticals, timing is everything. As patent protections near expiration, many companies scramble to maximize th…

Find the Money Before the Patent Dies: How to Identify Out-Licensing Targets Near Drug Patent Expiry — and Capture Value That Most Companies Leave on the Table Read Post »

Biotechblog
Scroll to Top